Localized Metabolomic Gradients in Patient-Derived Xenograft Models of GlioblastomaElizabeth C. Randall, Nathalie Y.R. Agar, Begoña Giménez et al.|Cancer Research|2019Cited by 99
Single cell spatial analysis reveals the topology of immunomodulatory purinergic signaling in glioblastomaShannon Coy, Sandro Santagata, Shu Wang et al.|Nature Communications|2022Cited by 88
Heterogeneous delivery across the blood-brain barrier limits the efficacy of an EGFR-targeting antibody drug conjugate in glioblastomaBianca M. Marin, Jann N. Sarkaria, Ann C. Mladek et al.|Neuro-Oncology|2021Cited by 81
Integrated mapping of pharmacokinetics and pharmacodynamics in a patient-derived xenograft model of glioblastomaElizabeth C. Randall, Nathalie Y.R. Agar, Kristina B. Emdal et al.|Nature Communications|2018Cited by 79
Multimodal platform for assessing drug distribution and response in clinical trialsBegoña Giménez, Nathalie Y.R. Agar, Ishwar N. Kohale et al.|Neuro-Oncology|2021Cited by 14